Trading Symbol: VNTAD until mid-February when the ... opportunities that may have been unavailable to us as Ventana Biotech, Inc. more easily." "These actions align our corporate identity with ...

Zhengye Biotechnology announces full exercise of ... The shares began trading on the Nasdaq Capital Market under the ticker symbol "ZYBT" on January 7, 2025. Funds from the IPO will be used ...

Metsera, along with Maze Therapeutics, gave U.S. health care first-time share sales its best month since October.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology ...

PHILADELPHIA and VANCOUVER, British Columbia, Jan. 27, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage ...

Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual ...

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

video animation black and white icon of molecule with numbers 0 and 1 of binary code, in nanotechnology or biotechnology concept, on a green chroma key background Royalty-free licenses let you pay ...

Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...